Synmosa Biopharma Market Cap

Synmosa Biopharma has a market cap or net worth of 17.77 billion as of July 21, 2025. Its market cap has increased by 12.38% in one year.

Market Cap

17.77B

Enterprise Value

18.44B

Revenue

5.72B

Ranking

n/a

PE Ratio

23.35

Stock Price

35.30

Market Cap Chart

Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 17.77B, an increase of 2,946.41%. That is a compound annual growth rate of 19.46%.

Market Cap History

Date	Market Cap	% Change
Jul 21, 2025	17.77B	22.60%
Dec 31, 2024	14.50B	-1.41%
Dec 29, 2023	14.71B	-8.20%
Dec 30, 2022	16.02B	128.36%
Dec 30, 2021	7.02B	2.96%
Dec 31, 2020	6.81B	20.87%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	188.45B
PharmaEssentia	181.63B
Bora Pharmaceuticals Co., LTD.	87.20B
Lotus Pharmaceutical	58.11B
Oneness Biotech	31.42B
Polaris Group	29.16B
Center Laboratories	26.92B
TaiMed Biologics	23.62B

Market Cap Rankings